-
The genomics of resistance to immunodeficiency virus (GRIV) Cohort was established in France in 1995 to generate a large database for genetic studies to identify host genes associated with rapid progression and long-term non-progression to AIDS.
-
Even HIV-infected individuals who have the greatest challenges in adhering to their antiretroviral (ART) can achieve high adherence on a regimen of one pill taken daily, research shows.
-
Results of a new analysis of 21 major U.S. cities from the Centers for Disease Control and Prevention indicate approximately one in five (19%) men who have sex with men (MSM) in a study is infected with HIV, and nearly half (44%) of those men are unaware of their infection.
-
On Nov. 10, 2010, the Food and Drug Administration (FDA) approved tessamorelin (Egrifta®) to treat HIV patients with lipodystrophy, a condition in which excess fat develops in different areas of the body, most notably around the liver, stomach, and other abdominal organs (visceral body fat).
-
The Centers for Disease Control and Prevention has released new guidelines for the treatment of persons who have or are at risk for sexually transmitted diseases (STDs).
-
The Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure is currently updating its work in JNC-7 in an effort to help physicians provide safe, effective, and patient-centered care for those with elevated blood pressure.
-
-
Avian influenza has created an economic disaster in parts of Asia. While the number of associated identified human infections has, to date, not reached 100 cases, the possibility of a public health disaster looms since the outbreak of avian influenza may be setting the stage for the next human influenza pandemic.
-
Samples obtained by swabbing both nares of almost 10,000 individuals > 1 year of age in the US National Health and Nutrition Survey (NHANES) in 2001-2002 were cultured on mannitol salt agar. S. aureus was identified in 32.4% of subjects and 0.8% were colonized with methicillin resistant S. aureus(MRSA).
-
Adverse drug events (ADES) are unwanted consequences of drug therapy and have important implications for each patient, the treating physician, and the institution itself. When assessing adverse effects, prescribing healthcare workers should pay particular attention to ADEs that interrupt the patients therapeutic regimen and hence increase the patients length of stay in the hospital.
